Treatment delays limit the social value generated by chimeric antigen receptor (CAR) T-cell therapy for the treatment of pediatric acute lymphoblastic leukemia and diffuse large B-cell lymphoma.
Rebecca Kee, BA
Advertisement
Articles by Rebecca Kee, BA
Advertisement
Latest Updated Articles
- The Potential Impact of CAR T-Cell Treatment Delays on Society
Published: August 13th 2019 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
3
Weight Loss Medications Show Promise in MASLD, MASH
4
Addressing Common Stigmas in Weight Loss: David Rometo, MD
5
